HSHarith Swadi

Harith Swadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Harith Swadi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lessons from an investigation of seclusion at an older adolescent inpatient unit

    by Harith Swadi, Candace Bobier

    Objective: To determine the rate, indications and process for using seclusion for patients undergoing treatment at an older adolescent inpatient unit. Method: Data were gathered prospectively and retrospectively as part of a quality assurance initiative at the Christchurch Youth Inpatient Unit (YIU); paper, electronic and legal documentation were examined. Results: During the time period of the investigation, approximately 13% of individuals admitted to the unit were secluded. Psychosis, involuntary admission and Maori ethnicity were significantly associated with the use of seclusion with aggression being the most documented indication. The vast majority of seclusions occurred within the first seven days of admission and over half utilized pro re nata medication prior to seclusion. Conclusions: Opportunities exist for intensifying and focusing efforts to minimize the use of seclusion and restraint, particularly during the first week of hospitalization.


  • Lessons from an Audit of Psychoeducation at an Older Adolescent Inpatient Unit

    by Harith Swadi, Candace Bobier, Lisa Price, Brian Craig

    Objectives: The aim of this paper was to determine if patients undergoing treatment at an older adolescent inpatient unit receive psychoeducation according to the unit philosophy of providing timely and pertinent information regarding illness/diagnosis, medication, diet, outpatient follow-up, and alcohol/ drug use. Methods: Data were gathered prospectively as part of a quality assurance initiative at the Christchurch Youth Inpatient Unit. Patients were interviewed by a registered nurse using a structured audit tool. Results: Participants reported receiving adequate information on medication and illness, and most received information on outpatient follow-up and alcohol and drug use. However, the majority reported a lack of information/ advice about diet. Patients' reported awareness of relapse prevention and the relationship of alcohol and other drugs use to medication and treatment was lower than expected. Conclusions: The audit highlighted areas of discrepancy between information staff believed they had delivered and information youth perceived as received. Psychiatric staff working with young people need be aware of the timing, language and mode of delivery of psychoeducation to enable their patients to ‘take in’ the information provided.


  • A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents

    by Harith S. Swadi, Brian J. Craig, Nabeel Z. Pirwani, Valerie C. Black, Jill C. Buchan, Candace M. Bobier

    The objective of this study was to evaluate the efficacy and tolerability of quetiapine in the treatment of first onset psychosis in older adolescents using risperidone as a comparator. Twenty-two patients with first onset psychosis were randomized to receive quetiapine (up to 800 mg/day) or risperidone (up to 6 mg/day) for 6 weeks. Raters blind to treatment assignment performed outcome symptom ratings. No statistical differences emerged in terms of efficacy or tolerability between the two drugs. However, there were some clinically notable differences that seem to favour the efficacy of risperidone over quetiapine. Patients taking quetiapine, although improved, showed less clinical improvement on scores for total positive and negative symptoms, clinical global severity and depression at 6 weeks than patients taking risperidone. Although both treatments were associated with weight gain and sedation, more patients on quetiapine experienced over 10% weight gain. However, fewer patients who were taking quetiapine required anticholinergic medication or experienced extrapyramidal side effects than patients taking risperidone. Risperidone was significantly more likely to be associated with elevation in serum prolactin levels in this population. In conclusion, the results in this small trial show that adolescent patients may benefit more from treatment with risperidone than quetiapine. However, those susceptible to side effects, particularly hyperprolactinaemia, may be more suitable for treatment with quetiapine.


  • Hospital Admission in Adolescents with acute Psychiatric Disorder: How Long should it be?

    by Harith Swadi, Candace Bobier

    Objective: To determine the length of stay in hospital for youth with acute psychiatric illness, and the treatment outcome. Methods: Diagnostic and Statistical Manual of Mental Disorders(4th edn;DSM-IV) psychiatric diagnosis, clinical outcome and the length of stay were sys-tematically gathered for admissions over an 18month period at the Christchurch Youth Inpatient Unit (YIU). Clinical outcome data were collected at admission,3 weeks after admission and at discharge, using the Health of the Nation Out-come Scale for Children and Adolescents (HoNOSCA). The length of stay was determined retrospectively. Discharge was decided on clinical grounds. Results: During the 18 months of the investigation, 72 subjects were admitted for the treatment of acute mental illness. The most common diagnostic category was mood disorder (n = 39, 54%), followed by anxiety or adjustment disorder (n = 18, 25%), and major psychosis (n = 15, 21%). The mean length of admission for the whole population was 27.3 days, 23.7 days for mood disorders, 18.9 days for anxiety disorders and 46.9 days for the major psychosis diagnostic groups. According to HoNOSCA clinician ratings, the major portion of the improvement occurred during the first 3 weeks of admission. Conclusions: For the majority of youth with acute psychiatric illness, a relatively short stay in hospital is feasible, because most health gains tend to occur early during an admission.


  • Substance Use Disorder Comorbidity Among Inpatient Youths With Psychiatric Disorder

    by Harith Swadi, Candace Bobier

    Objective: Substance abuse/dependence has been reported to show significant association with psychopathology, and is likely to influence the course and outcome of psychiatric illness. The aim of this study was to determine the rate of substance use disorders (other than alcohol) comorbidity among inpatient adolescents with severe Axis 1 psychiatric disorder. Method: A retrospective analysis of systematically collected data was carried out. The subjects were 16–18-year-old youths, admitted to an inpatient unit for severe psychiatric disorder. The data collection process utilized the DSM-IV criteria for diagnostic categorization of psychiatric disorder and substance use disorder. Demographic data, and data on suicide attempts were also collected. Results: Over a period of one year (March 2001–March 2002), 62 patients were admitted to the Christchurch Youth Inpatient Unit; 40 (64.5%) had a comorbid Substance Abuse Disorder (SAD) according to DSM-IV criteria and none had a Substance Dependence Disorder. The vast majority involved cannabis and stimulants. Sixty per cent of those with mood disorder, 63% of those with anxiety disorder and 80% of those with schizophrenia spectrum disorder had a comorbid SAD. Internalizing problems, especially mood disorders, predominated among those with SAD reflecting the Unit's admission criteria. There were no differences in attempted suicide rates between those with SAD and those without SAD, but those with SAD were more likely to have unstable accommodation/living arrangements than those without SAD. Conclusions: Our findings confirm previous reports suggestive of high rates of SAD comorbidity among youth with severe psychiatric illness. There are clinical and process implications for these findings particularly identification of substance use disorders and their treatment as well as resource availability and staff training.